Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29,697 INR | -0.12% | -0.90% | -20.40% |
Apr. 01 | 3M India Limited Announces Agreements Executes in Relation to the Health Care Business | CI |
Feb. 12 | 3M India Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 59.14 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Consumer Goods Conglomerates
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.40% | 4B | - | ||
+11.13% | 865B | D+ | ||
+0.03% | 239B | - | C | |
+28.62% | 180B | B | ||
-6.63% | 128B | B- | ||
+42.13% | 87.6B | B+ | ||
-11.13% | 53.76B | C+ | ||
+41.87% | 38.73B | A | ||
-27.13% | 37.3B | - | - | |
+71.52% | 31.07B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 3MINDIA Stock
- 3MINDIA Stock
- Ratings 3M India Limited